HPR169 The Impact of Exercise on Health Expenditure in Children von Balkhi, B., Alshehri, N.

Volltext

OP12 Adherence to Intravenous to Oral Switching Criteria in a Tertiary Governmental Hospital in Riyadh, Saudi Arabia von Alshehri, N., Balkhi, B.

Volltext

HTA276 Comparison of Health Technology Assessment Systems: A Review of Their Impact on Expenditure and Outcomes von Balkhi, B., Alshehri, N.

Volltext

HSD74 Cost Savings as a Result of Biosimilar Medications Adoption in One of the Tertiary Governmental Hospitals in Riyadh, Saudi Arabia von Alshehri, N., Balkhi, B.

Volltext

EE346 Evaluating the Economic Burden of Osteoporosis in the United States: Insights from a MEPS-Based Analysis von Balkhi, B., Alshehri, N.

Volltext

HSD53 Effect of COVID-19 Pandemic on the Delivery Time and the Point of Re-Order of Pharmaceuticals at the Logistics Services in a Governmental Hospital in Riyadh Saudi Arabia von Alshehri, N., Balkhi, B.

Volltext

POSA2 Clinical Features and Management of COVID 19 in Saudi Arabia von Ezzi, A, Balkhi, B

Volltext

Assessment Of Pharmaceutical Products Approved By The United States Fda And Registered In Peru von Araujo, L, Balkhi, B, Seoane-Vazquez, E

Volltext

Trends In Medicaid Fee-For-Service Outpatient Drug Utilization, Expenditures And Pharmacy Reimbursement Rates (2010-2012) von Balkhi, B, Alshehri, A, Szeinbach, S.L, Seoane-Vazquez, E

Volltext

POSC160 Economic Evaluation of Using Ribociclib in HER2- Negative Breast Cancer Patients: A Systematic Review of Evidence von Alotaibi, W, Alhamdan, M, Balkhi, B

Volltext

Analysis of 2011 medicaid fee-for-service outpatient drug utilization, expenditures and pharmacy reimbursement rates von Alshehri, A, Balkhi, B, Seoane-Vazquez, E, Szeinbach, S.L

Volltext

POSC210 Real- World Effectiveness and Safety of Rivaroxaban in Patients with NON-Valvular Atrial Fibrillation (NVAF) and Venous Thromboembolism (VTE) in Saudi Arabia von Alosaimi, H, Alqahtani, S, Balkhi, B, Asiri, Y

Volltext

PMS23 Cost Effectiveness Analysis of Certolizumab in Combination with Methotrexate in Patients with Moderate to Severe Rheumatoid Arthritis in Saudi Arabia von Alghamdi, A., Alothaim, A., Almalaq, H., Balkhi, B., Alshehri, N.

Volltext

PCV50 Economic Burden of Major Cardiovascular Diseases and Ischemic Stroke in Saudi Arabia: A Cost of Illness Study von Altowaijri, A., Alshehri, N., Balkhi, B., Alghamdi, A.

Volltext

PHP12 Shortages of Systemic Antibiotics in the United States: A Public Health Concern von Balkhi, B, Araujo-Lama, L, Nguyen, D, Le, P, Seoane-Vazquez, E, Rodriguez-Monguio, R, Fox, E.R, Szeinbach, S.L

Volltext

PMS22 Direct Medical Cost of Osteoporosis in Saudi Arabia: A Single-Center Retrospective Cost Analysis von Balkhi, B., Alqusair, S., Alotaibi, B., Alghamdi, A., AlRuthia, Y., Fouda, M.

Volltext

PCN112 Estimating Resources Utilization and Health Care Costs Related to Colorectal Cancer Patients in Saudi Arabia von Balkhi, B., Alharbi, A., Al Najjar, M., Alghamdi, A., AlRuthia, Y., Alqahtani, S.

Volltext

PMS14 Economic Burden of Rheumatoid Arthritis in Saudi Arabia: A Single-Center Cost of Illness Study von Alghamdi, A., Alsaif, K., Alsahli, M., Omair, M., Almohammed, O., Almalaq, H., Alshehri, N., Balkhi, B.

Volltext

Changes in the utilization of osteoporosis drugs after the 2010 FDA bisphosphonate drug safety communication von Balkhi, Bander, Seoane-Vazquez, Enrique, Rodriguez-Monguio, Rosa

Volltext

PDB20 - Polypharmacy Use Among Patients with Diabetes: A Cross-Sectional Retrospective Study von Alwhaibi, M, Balkhi, B, Alhawassi, T, Alkofide, H, Alduhaim, N, Alabdulali, R, Drweesh, H, Sambamoorthi, U

Volltext